Concord Biotech Ltd.

₹1510

+ 57.40 (3.95%)

04:01 pm - close price

BSE: CONCORDBIO

NSE: CONCORDBIO

Industry: Pharmaceuticals & Drugs

House: Private

Overview

Events:

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Ratios

Reported EPS

Bad: 2Current: 24.94Good: 5

✅

Adjusted EPS

Bad: 3Current: 24.94Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 18.04Good: 20

🟡

Current Ratio

Bad: 1Current: 7.39Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 13.54Good: 15

🟡

Debt to Total Assets

N/A

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 24.94Good: 5

✅

Adjusted EPS

Bad: 3Current: 24.94Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 18.04Good: 20

🟡

Current Ratio

Bad: 1Current: 7.39Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 13.54Good: 15

🟡

Debt to Total Assets

N/A

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Peer Comparison

Consolidated

Peer comparison with financial metrics
company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.02	14.85	26.44	19.78	47.84	47.84	16.00	2.82	2.31	0.05	45.61	0.61	36.73	29.07	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.31	16.19	32.46	24.43	96.91	96.91	30.00	4.12	2.76	0	142.17	0.54	61.36	51.99	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	9.88	11.83	13.53	9.92	48.02	48.02	13.00	3.44	2.50	0.01	97.04	1.00	25.47	19.45	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	7.37	26.76	16.55	10.86	63.92	63.92	38.00	1.13	0.75	1.76	8.46	0.68	66.03	43.86	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	11.81	19.69	13.66	9.73	50.10	50.10	1.00	1.27	0.91	0.43	16.09	1.21	17.39	13.62	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	8.03	11.69	17.11	12.34	50.25	50.25	8.00	1.79	1.34	0.20	15.43	0.65	24.97	16.85	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	16.12	27.11	16.95	12.42	116.64	116.64	18.00	1.90	1.42	0.26	16.82	1.30	19.83	15.71	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	7.00	12.69	19.93	12.98	46.34	46.34	1.00	1.07	0.74	0.37	4.62	0.54	43.29	29.32	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	6.64	9.93	7.91	5.04	60.34	60.34	4.00	1.81	1.15	0.20	14.31	1.32	21.60	14.33	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	13.44	18.29	13.43	10.43	192.54	192.54	53.00	2.55	1.86	0.12	18.86	1.29	27.54	23.18	6.85	26.10	0.64

Scroll horizontally to see more columns

Quarterly Results

In Rs. Cr.	2023-09	2023-12	2024-03	2024-06
Net Sales	262.35	240.80	318.97	215.80
Expenditure+	143.16	134.87	184.68	134.52
Other Income+	8.13	8.19	10.81	10.31
Operating Profit	119.19	105.93	134.29	81.28
Interest	0.84	0.49	0.46	0.24
Depreciation and Amortization	13.29	13.54	13.72	13.18
Profit Before Tax	109.70	103.10	128.72	79.52
Tax+	28.69	25.53	33.70	19.93
Net Profit	81.02	77.57	95.02	59.59

Profit & Loss

In Rs. Cr.	202203	202303	202403	202503	202603
Sales	7129.33	85316.82	101693.92	120008.69	105489.07
Operational Expenses+	4390.08	50458.93	58475.00	69324.30	68695.06
Operating Profit	2739.25	34857.89	43218.92	50684.39	36794.01
Other Income	234.16	3530.93	3378.00	4444.67	5235.53
OPM %	38.42	40.86	42.50	42.23	34.88
Depreciation and Amortisation	500.50	5403.24	5359.15	5437.35	7445.86
Interest	61.35	980.17	318.40	104.17	82.34
Profit Before Tax	2375.18	32201.34	41256.50	49455.33	34464.72
Tax	621.95	8191.16	10446.18	12291.10	8541.81
Net Profit	1749.29	24008.57	30810.32	37164.23	26090.59

Balance Sheet

In Rs. Cr.	202203	202303	202403	202503	202603
Assets+	15018.69	151398.18	170070.85	203425.15	223179.05
Liabilities+	15018.69	151398.18	170070.85	203425.15	223179.05

Cash Flow Statement

In Rs. Cr.	202203	202303	202403	202503	202603
Cash from Operating Activity+	2074.75	24600.18	26546.71	24451.69	26688.13
Cash from Investing Activity	-1117.88	-15795.01	-15460.93	-15998.65	-14272.36
Cash from Financing Activity	-1001.64	-8521.94	-9921.49	-9876.80	-11287.62
Net Cash Flow	-44.77	283.23	1164.29	-1423.76	1128.15
Opening Cash & Cash Equivalents	51.44	66.69	349.92	1514.21	90.45
Closing Cash & Cash Equivalents	6.67	349.92	1514.21	90.45	1218.60

Shareholder Pattern

In %	JUN'26	MAR'26	DEC'25	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24
Promoters+	44.08	44.08	44.08	44.08	44.08	44.08	44.08	44.08	44.08	44.08
Public+	55.92	55.92	55.92	55.92	55.92	55.92	55.92	55.92	55.92	55.92
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	83325	82249	81815	82650	82045	81219	82004	84298	80737	83296

Corporate Actions

177 events in the last 3 years

Profit & Loss

In Rs. Cr.	202203	202303	202403	202503	202603
Sales	7129.33	85316.82	101693.92	120008.69	105489.07
Operational Expenses+	4390.08	50458.93	58475.00	69324.30	68695.06
Operating Profit	2739.25	34857.89	43218.92	50684.39	36794.01
Other Income	234.16	3530.93	3378.00	4444.67	5235.53
OPM %	38.42	40.86	42.50	42.23	34.88
Depreciation and Amortisation	500.50	5403.24	5359.15	5437.35	7445.86
Interest	61.35	980.17	318.40	104.17	82.34
Profit Before Tax	2375.18	32201.34	41256.50	49455.33	34464.72
Tax	621.95	8191.16	10446.18	12291.10	8541.81
Net Profit	1749.29	24008.57	30810.32	37164.23	26090.59

Quarterly Results

In Rs. Cr.	2023-09	2023-12	2024-03	2024-06
Net Sales	262.35	240.80	318.97	215.80
Expenditure+	143.16	134.87	184.68	134.52
Other Income+	8.13	8.19	10.81	10.31
Operating Profit	119.19	105.93	134.29	81.28
Interest	0.84	0.49	0.46	0.24
Depreciation and Amortization	13.29	13.54	13.72	13.18
Profit Before Tax	109.70	103.10	128.72	79.52
Tax+	28.69	25.53	33.70	19.93
Net Profit	81.02	77.57	95.02	59.59

Balance Sheet

In Rs. Cr.	202203	202303	202403	202503	202603
Assets+	15018.69	151398.18	170070.85	203425.15	223179.05
Liabilities+	15018.69	151398.18	170070.85	203425.15	223179.05

Ratios

Reported EPS

Bad: 2Current: 24.94Good: 5

✅

Adjusted EPS

Bad: 3Current: 24.94Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 18.04Good: 20

🟡

Current Ratio

Bad: 1Current: 7.39Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 13.54Good: 15

🟡

Debt to Total Assets

N/A

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 24.94Good: 5

✅

Adjusted EPS

Bad: 3Current: 24.94Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 18.04Good: 20

🟡

Current Ratio

Bad: 1Current: 7.39Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 13.54Good: 15

🟡

Debt to Total Assets

N/A

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Cash Flow Statement

In Rs. Cr.	202203	202303	202403	202503	202603
Cash from Operating Activity+	2074.75	24600.18	26546.71	24451.69	26688.13
Cash from Investing Activity	-1117.88	-15795.01	-15460.93	-15998.65	-14272.36
Cash from Financing Activity	-1001.64	-8521.94	-9921.49	-9876.80	-11287.62
Net Cash Flow	-44.77	283.23	1164.29	-1423.76	1128.15
Opening Cash & Cash Equivalents	51.44	66.69	349.92	1514.21	90.45
Closing Cash & Cash Equivalents	6.67	349.92	1514.21	90.45	1218.60

Events:

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Shareholder Pattern

In %	JUN'26	MAR'26	DEC'25	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24
Promoters+	44.08	44.08	44.08	44.08	44.08	44.08	44.08	44.08	44.08	44.08
Public+	55.92	55.92	55.92	55.92	55.92	55.92	55.92	55.92	55.92	55.92
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	83325	82249	81815	82650	82045	81219	82004	84298	80737	83296

Peer Comparison

Consolidated

Peer comparison with financial metrics
company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.02	14.85	26.44	19.78	47.84	47.84	16.00	2.82	2.31	0.05	45.61	0.61	36.73	29.07	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.31	16.19	32.46	24.43	96.91	96.91	30.00	4.12	2.76	0	142.17	0.54	61.36	51.99	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	9.88	11.83	13.53	9.92	48.02	48.02	13.00	3.44	2.50	0.01	97.04	1.00	25.47	19.45	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	7.37	26.76	16.55	10.86	63.92	63.92	38.00	1.13	0.75	1.76	8.46	0.68	66.03	43.86	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	11.81	19.69	13.66	9.73	50.10	50.10	1.00	1.27	0.91	0.43	16.09	1.21	17.39	13.62	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	8.03	11.69	17.11	12.34	50.25	50.25	8.00	1.79	1.34	0.20	15.43	0.65	24.97	16.85	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	16.12	27.11	16.95	12.42	116.64	116.64	18.00	1.90	1.42	0.26	16.82	1.30	19.83	15.71	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	7.00	12.69	19.93	12.98	46.34	46.34	1.00	1.07	0.74	0.37	4.62	0.54	43.29	29.32	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	6.64	9.93	7.91	5.04	60.34	60.34	4.00	1.81	1.15	0.20	14.31	1.32	21.60	14.33	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	13.44	18.29	13.43	10.43	192.54	192.54	53.00	2.55	1.86	0.12	18.86	1.29	27.54	23.18	6.85	26.10	0.64

Scroll horizontally to see more columns

Concord Biotech Ltd.

₹1510

+ 57.40 (3.95%)

04:01 pm - close price

BSE: CONCORDBIO

NSE: CONCORDBIO

Industry: Pharmaceuticals & Drugs

House: Private

Overview

Corporate Actions

177 events in the last 3 years